Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
焦虑症谱系中逃避、回避和接近的建模和调节机制
基本信息
- 批准号:10215704
- 负责人:
- 金额:$ 20.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-02 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAmbulatory CareAmygdaloid structureAnhedoniaAnimalsAnxietyAreaAversive StimulusBasic ScienceBehaviorClinicalClinical ResearchCognitive TherapyCollaborationsComputer ModelsConflict (Psychology)Coping BehaviorCorpus striatum structureDataDecision MakingDevelopmentDevelopment PlansDiseaseDisease remissionDorsalDropoutEducational workshopEnsureFosteringFrightFunctional Magnetic Resonance ImagingFutureGoalsGrantHealthcareHumanImpairmentIndividualInstitutionInternationalInterventionKnowledgeLaboratoriesMajor Depressive DisorderMapsMediatingMedicalMental DepressionMental HealthMental disordersMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMethodsModelingMotivationNational Institute of Mental HealthNeurosciencesOutcomeParticipantPatientsPatternPhysiologyPrefrontal CortexPreparationPsychiatryPublicationsReflex actionResearchResearch Domain CriteriaResearch MethodologyResearch PersonnelResearch TrainingRewardsScienceSouth CarolinaStimulusSymptomsTechniquesTestingTrainingTranslational ResearchTreatment outcomeUniversitiesVentral StriatumWorkWritinganxiety spectrum disordersanxiety-related disordersanxiousapproach avoidance behavioravoidance behaviorbasecareercareer developmentclinical practicecopingcosteffective therapyevidence basehands on researchimprovedimproved outcomemultimodalityneural circuitneuroregulationnoninvasive brain stimulationnovelpre-clinicalprecision medicinepreventreduce symptomsrepetitive transcranial magnetic stimulationresponseskillssubstance misusesymposiumtherapy outcometool
项目摘要
PROJECT ABSTRACT
The proposed K23 Mentored Patient-Oriented Research Career Development Award launches a line of work
aiming to comprehensively target mechanisms of avoidance in anxiety and other disorders; and, it provides Dr.
Christopher Sege with skills necessary to becoming a leading clinical researcher. Dr. Sege’s primary clinical
research career goal is to use cutting-edge translational science to improve mental health care by targeting
precise disorder mechanisms. Need for this research is significant and consistent with NIMH priorities and the
RDoC framework. Avoidance is a core target of anxiety and related disorder treatment, but avoidant behaviors
often persist after symptom reduction and keep many from engaging in treatment at all. Novel methods to
target multiple motive drivers of avoidance early in treatment are needed to improve retention and outcome
especially for the 20% of individuals who do not benefit from and 40% who do not complete treatment. Basic
science provides critical clues as to the multiple mechanisms of real-world avoidance that may be indirectly or
inadequately addressed by current treatment techniques. Crucial goals of work proposed here is to determine
how these mechanisms drive clinical behavior and support subsequent work that develops direct intervention
tools. The proposed project uses direct neurostimulation (repetitive transcranial magnetic stimulation; rTMS) in
concert with precise experimental methods to test how specific reactive (escape) and proactive (avoidance)
coping neurocircuits can be modulated to alter downstream fear and approach-avoid decision-making.
Subsequent R-level applications build on this work to determine coping profiles of treatment completers versus
non-completers, and to test how profiles can be more precisely targeted to improve outcomes. A team of
expert mentors (George, Liu, McTeague, Mobbs, Uhde) will use their extensive knowledge in research-based
and clinical neurostimulation, advanced fMRI analysis and research methods, and creation of translational
science-informed treatment adjuvants to support Dr. Sege in his development. Mentorship, hands-on research
tutorials, coursework, seminars/ workshops, and international conference attendance afforded by the K23 will
ensure that Dr. Sege achieves his career goals to: 1) develop expertise in cutting-edge neurostimulation for
research and clinical use, 2) develop expertise in fMRI analysis and research tools for use in concert with
rTMS to more precisely target ecologically-relevant avoidance behavior, and; 3) develop expertise in creating
adjuvants that improve cognitive behavior therapy outcomes through application of translational science. The
proposed K23 will also foster development in areas of publication, grant writing, and inter-departmental
collaboration, all at an institution – the Medical University of South Carolina – which has a strong track record
and commitment to early stage investigators. Proposed K23 activities will prepare Dr. Sege to become a
cutting-edge clinical researcher and a leader in the development of a precision medicine of psychiatry.
项目摘要
拟议的 K23 以患者为导向的研究职业发展奖启动了一系列工作
旨在全面针对焦虑和其他疾病的回避机制;并且,它提供了博士。
Christopher Sege 拥有成为领先临床研究员所需的技能。 Sege 博士的主要临床
研究职业目标是利用尖端的转化科学来改善心理健康护理
精确的紊乱机制。这项研究的需求非常大,并且与 NIMH 的优先事项和
RDoC 框架。回避是焦虑和相关疾病治疗的核心目标,但回避行为
通常在症状减轻后仍然存在,并使许多人根本无法接受治疗。新方法
需要在治疗早期针对回避的多种动机驱动因素,以提高保留率和结果
尤其是对于 20% 未从治疗中受益和 40% 未完成治疗的个体而言。基本的
科学提供了关于现实世界回避的多种机制的关键线索,这些机制可能是间接或间接的
目前的治疗技术不足以解决这一问题。这里提出的工作的关键目标是确定
这些机制如何驱动临床行为并支持后续开展直接干预的工作
工具。拟议的项目使用直接神经刺激(重复经颅磁刺激;rTMS)
结合精确的实验方法来测试具体的反应(逃避)和主动(回避)
可以调节应对神经回路来改变下游的恐惧和回避决策。
随后的 R 级应用程序建立在这项工作的基础上,以确定治疗完成者与
未完成者,并测试如何更精确地定位个人资料以改善结果。一个团队
专家导师(George、Liu、McTeague、Mobbs、Uhde)将利用他们丰富的知识进行基于研究的研究
和临床神经刺激、先进的功能磁共振成像分析和研究方法以及转化模型的创建
科学指导的治疗佐剂支持 Sege 博士的发展。指导、实践研究
K23 提供的教程、课程作业、研讨会/讲习班以及参加国际会议将
确保 Sege 博士实现他的职业目标:1) 发展尖端神经刺激方面的专业知识
研究和临床使用,2)开发功能磁共振成像分析和研究工具方面的专业知识,以便与
rTMS 更精确地针对生态相关的回避行为; 3)培养创造方面的专业知识
通过应用转化科学来改善认知行为治疗结果的佐剂。这
拟议的 K23 还将促进出版、资助写作和跨部门领域的发展
合作全部在一个机构——南卡罗来纳医科大学——拥有良好的记录
以及对早期研究人员的承诺。拟议的 K23 活动将使 Sege 博士成为一名
尖端临床研究员和精神病学精准医学开发的领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Sege其他文献
Christopher Sege的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Sege', 18)}}的其他基金
Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
焦虑症谱系中逃避、回避和接近的建模和调节机制
- 批准号:
10362709 - 财政年份:2021
- 资助金额:
$ 20.9万 - 项目类别:
Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
焦虑症谱系中逃避、回避和接近的建模和调节机制
- 批准号:
10576356 - 财政年份:2021
- 资助金额:
$ 20.9万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:














{{item.name}}会员




